Dr. Bright Pearson Thilagar, MD

Dr. Thilagar practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Thilagar's NPI, 1225340474, was assigned on July 3, 2010. Dr. Thilagar holds Minnesota license 68817.

Dr. Thilagar's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Thilagar's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Thilagar to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thilagar practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Thilagar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Thilagar's licenses on file in 3 states: Minnesota, Michigan and New York.

CMS data shows 192 Medicare services from Dr. Thilagar across 5 procedure codes in 2024, for 110 Medicare patients. Medicare paid $18,868 for them.

CMS counts 110 Medicare patients who saw Dr. Thilagar in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Thilagar's median patient age at 57, with 78% women.

In 2024, Dr. Thilagar wrote 105 Medicare Part D claims for 37 patients. 89% of them were for generic drugs. CMS names the drug for 31 of them, across 2 drugs with 11 or more claims each, at $361 in total drug cost. In 2023, CMS named 48 claims across 2 drugs.

Dr. Thilagar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thilagar as offering telehealth.

Dmand AI links 14 papers to Dr. Thilagar, published from 2020 to 2025. 2024 was the busiest year, with 2. The most frequent topics are COVID-19, Anxiety and Pulmonary Disease, Chronic Obstructive. Dr. Thilagar has published most often in Gastro Hep Adv. Dr. Thilagar's most frequent co-authors are Arul Velavan Chandran, MD, Kayla Christine Finnegan, MD and Ravindra Ganesh, MD.

CMS Open Payments shows 5 general payments to Dr. Thilagar from 3 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $269.